- 86% of patients achieved primary endpoint of ≥50% thyroid nodule volume reduction at six months.
- Median nodule volume reduction was 72% with zero serious adverse events reported.
- ThyPRO-39 Quality of Life score improved by 78%, supporting commercial and regulatory progress.
Signal #160519 · SEC 8-K
$PLSE SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $PLSE filing catalyst
Why did $PLSE trigger an AI stock catalyst alert?
$PLSE triggered a Stock Catalyst AI alert on 2026-11-06 13:40:56 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Pulse Biosciences Reports Positive PRECISE-BTN Six-Month Interim Data. Key points: - 86% of patients achieved primary endpoint of ≥50% thyroid nodule volume reduction at six months. - Median nodule volume reduction was 72% with zero serious adverse events reported. - ThyPRO-39 Quality of Life score improved by 78%, supporting commercial and regulatory progress.
How did $PLSE stock react after the SEC filing?
After the SEC 8-K for $PLSE, observed market reaction: T0 price $53.07; 4h move -0.67%; peak move +7.16%. Past moves do not guarantee future results.
Where can I get real-time $PLSE SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $PLSE via Telegram and the VIP Web Terminal from €10/month.